BRPI0514383A - compostos e composições úteis como inibidores de catepsina s - Google Patents
compostos e composições úteis como inibidores de catepsina sInfo
- Publication number
- BRPI0514383A BRPI0514383A BRPI0514383-7A BRPI0514383A BRPI0514383A BR PI0514383 A BRPI0514383 A BR PI0514383A BR PI0514383 A BRPI0514383 A BR PI0514383A BR PI0514383 A BRPI0514383 A BR PI0514383A
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- compositions useful
- cathepsin inhibitors
- cathepsin
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
COMPOSTOS E COMPOSIçõES úTEIS COMO INIBIDORES DE CATEPSINA S. A presente invenção refere-se ao uso de um composto do tipo 2-ciano-pirimidina da fórmula onde R~ 1~, R~ 2~, R~ 3~ e X são como definidos no relatório descritivo e nas reivindicações, na forma livre ou na forma de sal, e, onde possível, na forma tautomérica, como inibidor da atividade de catepsina S.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0418353.9A GB0418353D0 (en) | 2004-08-17 | 2004-08-17 | Organic compounds |
PCT/EP2005/008896 WO2006018284A1 (en) | 2004-08-17 | 2005-08-16 | Compounds and compositions useful as cathepsin s inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0514383A true BRPI0514383A (pt) | 2008-06-10 |
Family
ID=33042203
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0514383-7A BRPI0514383A (pt) | 2004-08-17 | 2005-08-16 | compostos e composições úteis como inibidores de catepsina s |
Country Status (16)
Country | Link |
---|---|
US (1) | US7704996B2 (pt) |
EP (1) | EP1781623A1 (pt) |
JP (1) | JP2008509959A (pt) |
KR (1) | KR20070036183A (pt) |
CN (2) | CN101671310A (pt) |
AR (1) | AR050786A1 (pt) |
AU (1) | AU2005274319A1 (pt) |
BR (1) | BRPI0514383A (pt) |
CA (1) | CA2575826A1 (pt) |
GB (1) | GB0418353D0 (pt) |
GT (1) | GT200500220A (pt) |
MX (1) | MX2007001952A (pt) |
PE (1) | PE20060647A1 (pt) |
RU (1) | RU2007109650A (pt) |
TW (1) | TW200621727A (pt) |
WO (1) | WO2006018284A1 (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100292298A1 (en) * | 2006-02-21 | 2010-11-18 | Agency For Science, Technology And Research | Method and reagents for treating hepatic fibrosis and inflammation |
EP2202228B1 (en) * | 2007-10-15 | 2014-12-10 | Takeda Pharmaceutical Company Limited | Amide compounds and use of the same |
EP2370423A4 (en) * | 2008-12-04 | 2012-05-30 | Glaxo Group Ltd | PROCESS FOR PREPARING A SPIROINDOLINE AND A PREVENT Therefor |
TWI402072B (zh) * | 2010-10-19 | 2013-07-21 | Lilly Co Eli | 組織蛋白酶s抑制劑化合物 |
WO2020201572A1 (en) | 2019-04-05 | 2020-10-08 | Université De Bretagne Occidentale | Protease-activated receptor-2 inhibitors for the treatment of sensory neuropathy induced by a marine neurotoxic poisoning |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0201976D0 (sv) * | 2002-06-24 | 2002-06-24 | Astrazeneca Ab | Novel compounds |
GB0220187D0 (en) | 2002-08-30 | 2002-10-09 | Novartis Ag | Organic compounds |
-
2004
- 2004-08-17 GB GBGB0418353.9A patent/GB0418353D0/en not_active Ceased
-
2005
- 2005-08-15 PE PE2005000946A patent/PE20060647A1/es not_active Application Discontinuation
- 2005-08-16 AU AU2005274319A patent/AU2005274319A1/en not_active Abandoned
- 2005-08-16 RU RU2007109650/04A patent/RU2007109650A/ru not_active Application Discontinuation
- 2005-08-16 TW TW094127954A patent/TW200621727A/zh unknown
- 2005-08-16 CA CA002575826A patent/CA2575826A1/en not_active Abandoned
- 2005-08-16 EP EP05782460A patent/EP1781623A1/en not_active Withdrawn
- 2005-08-16 WO PCT/EP2005/008896 patent/WO2006018284A1/en active Application Filing
- 2005-08-16 CN CN200910179114A patent/CN101671310A/zh active Pending
- 2005-08-16 GT GT200500220A patent/GT200500220A/es unknown
- 2005-08-16 CN CNA2005800344018A patent/CN101035768A/zh active Pending
- 2005-08-16 KR KR1020077003902A patent/KR20070036183A/ko not_active Application Discontinuation
- 2005-08-16 BR BRPI0514383-7A patent/BRPI0514383A/pt not_active IP Right Cessation
- 2005-08-16 US US11/573,451 patent/US7704996B2/en not_active Expired - Fee Related
- 2005-08-16 MX MX2007001952A patent/MX2007001952A/es not_active Application Discontinuation
- 2005-08-16 JP JP2007526382A patent/JP2008509959A/ja active Pending
- 2005-08-19 AR ARP050103494A patent/AR050786A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
PE20060647A1 (es) | 2006-08-11 |
AU2005274319A1 (en) | 2006-02-23 |
CN101035768A (zh) | 2007-09-12 |
JP2008509959A (ja) | 2008-04-03 |
GB0418353D0 (en) | 2004-09-22 |
TW200621727A (en) | 2006-07-01 |
KR20070036183A (ko) | 2007-04-02 |
AR050786A1 (es) | 2006-11-22 |
GT200500220A (es) | 2006-03-29 |
MX2007001952A (es) | 2007-05-09 |
RU2007109650A (ru) | 2008-09-27 |
US20090048230A1 (en) | 2009-02-19 |
CN101671310A (zh) | 2010-03-17 |
CA2575826A1 (en) | 2006-02-23 |
US7704996B2 (en) | 2010-04-27 |
EP1781623A1 (en) | 2007-05-09 |
WO2006018284A1 (en) | 2006-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6341555A2 (es) | Compuestos quimicos 251 | |
BRPI0512902A (pt) | derivados de ftalazina como inibidores de parp | |
BRPI0511621A (pt) | compostos orgánicos | |
MX2009005934A (es) | Compuestos organicos. | |
SMP201100019B (it) | Composti organici | |
ATE549336T1 (de) | Heteroarylverbindungen,zusammensetzungen daraus und ihre verwendung als proteinkinasehemmer | |
WO2008109181A3 (en) | Metalloprotease inhibitors containing a heterocyclic moiety | |
BRPI0511885A (pt) | derivados de cromona úteis como antagonistas de vanilóide | |
MX2009003834A (es) | Derivados de pirrolidina como inhibidores de iap. | |
TNSN06405A1 (en) | Quinazolinone derivatives useful as vanilloid antagonistes | |
NO20083694L (no) | Bruk av rylener som markorer for vaesker | |
NO20065114L (no) | Inhibitorer av IAP | |
GT200600134A (es) | Compuestos novedosos de derivados de aminosulfonilo | |
BRPI0606379A2 (pt) | triazolftalazinas | |
BRPI0518752A2 (pt) | 1-alquinil-2-arilàxi-alquil-amidas e uso do mesmo como fungicidas | |
IL198741A0 (en) | Hepatitis c virus inhibitor compounds, compositions containing the same and uses thereof | |
BR112013016595A2 (pt) | inibidores de neprilisina | |
WO2007019191A3 (en) | Thiazolopyrimidine kinase inhibitors | |
EA200801145A1 (ru) | Спироциклические производные хиназолина в качестве ингибиторов pde7 | |
ATE509920T1 (de) | Quadratsäurederivate als inhibitoren von histondeacetylase | |
UA107689C2 (en) | 3,4,4A,10B-TETRAHYDRO-1H-THIOPYRANO-[4, 3-c] ISOQUINOLINE DERIVATIVES | |
NO20085317L (no) | Imidazoazepinonforbindelser | |
BRPI0807066A8 (pt) | Combinações sinergísticas de compostos ativos fungicidas | |
MX2008016358A (es) | Derivados de tiazolil-urea como inhibidores de cinasa de fosfatidil-inositol-3. | |
NO20081207L (no) | Isoquinolines as IGF-1R inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012. |